{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:21:35Z","timestamp":1761718895650,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.01.080","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T03:38:11Z","timestamp":1581046691000},"page":"2572-2577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Alexandra J.","family":"Hendry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Hueston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic E.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.080_b0005","unstructured":"Centers for Disease Control & Prevention. Poliomyelitis. In: Hamborsky J, Kroger A, Wolfe S (editors). Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C: Public Health Foundation; 2015."},{"key":"10.1016\/j.vaccine.2020.01.080_b0010","first-page":"145","article-title":"Polio vaccines: WHO position paper - March, 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.01.080_b0015","unstructured":"World Health Organization. Poliomyelitis - Fact sheet.2017. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs114\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.080_b0020","unstructured":"World Health Organization. International travel and health - Poliomyelitis (Polio). Available from: https:\/\/www.who.int\/ith\/diseases\/polio\/en\/ [Accessed 22 January 2020]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0025","unstructured":"Global Polio Eradication Initiative. Global eradication of wild poliovirus type 2 declared, 20 September 201201Available from: http:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-of-wild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx [Accessed 15 June 2016]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0030","first-page":"1031","article-title":"Possible eradication of wild poliovirus type 3\u2013worldwide, 2012","volume":"63","author":"Kew","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0035","first-page":"350","article-title":"Global polio eradication: progress towards containment of poliovirus type 2, worldwide 2017","volume":"92","author":"Previsani","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"31","key":"10.1016\/j.vaccine.2020.01.080_b0040","first-page":"329","article-title":"Progress towards poliomyelitis eradication in Nigeria, January 2018 - May 2019","volume":"30","author":"Adamu","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.01.080_b0045","unstructured":"Africa Renewal, United Nations. Polio is no longer endemic in Nigeria \u2013 UN health agency. 201Available from: https:\/\/www.un.org\/africarenewal\/news\/polio-no-longer-endemic-nigeria-%E2%80%93-un-health-agency [Accessed 22 January 2020]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33321\/cdi.2002.26.13","article-title":"Polio eradication in Australia and the world","volume":"26","author":"Roche","year":"2002","journal-title":"Communicable Dis Intellig Quart Rep"},{"key":"10.1016\/j.vaccine.2020.01.080_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid1501.080791","article-title":"Imported case of poliomyelitis, Melbourne, Australia, 2007","volume":"15","author":"Stewardson","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.080_b0060","first-page":"720","article-title":"Certification of poliomyelitis eradication\u2013the Americas","volume":"43","author":"Centers for Disease Control & Prevention","year":"1994","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0065","first-page":"1","article-title":"Certification of poliomyelitis eradication\u2013Western Pacific Region","volume":"50","author":"Centers for Disease Control & Prevention","year":"2001","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0070","first-page":"572","article-title":"Certification of poliomyelitis eradication\u2013European Region","volume":"51","author":"Centers for Disease Control & Prevention","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0075","first-page":"500","article-title":"Polio-free certification of the WHO South-East Asia Region","volume":"89","author":"Anonymous","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.01.080_b0080","unstructured":"National Centre for Immunisation Research and Surveillance. Vaccination history tables - Significant events in polio vaccination practice in Australia. 2015. Available from: http:\/\/www.ncirs.org.au\/sites\/default\/files\/2018-11\/Polio-history-July-2018.pdf [Accessed 15 July 2018]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0085","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health, Canberra; 2018. Available from: https:\/\/immunisationhandbook.health.gov.au\/ [Accessed 15 June 2018]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0090","first-page":"470","article-title":"Progress Toward Polio Eradication - Worldwide, 2015\u20132016","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0095","first-page":"1189","article-title":"Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018","volume":"67","author":"Jorba","year":"2018","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2020.01.080_b0100","unstructured":"World Health Organization. Circulating vaccine-derived poliovirus - Papua New Guinea. 2018. Available from: https:\/\/www.who.int\/csr\/don\/02-July-2018-polio-png\/en\/ [Accessed 12 February 2019]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0105","unstructured":"World Health Organization. Circulating vaccine-derived poliovirus type 1 - Indonesia. 2019. Available from: https:\/\/www.who.int\/csr\/don\/27-february-2019-polio-indonesia\/en\/ [Accessed 14 November 2019]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0110","unstructured":"World Health Organization. Circulating vaccine-derived poliovirus type 1 - The Philippines. 2019. Available from: https:\/\/www.who.int\/csr\/don\/24-october-2019-polio-the-philippines\/en\/ [Accessed 14 November 2019]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0115","unstructured":"World Health Organization. Polio eradication and endgame strategic plan (2013-2018). 2013. Available from: http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf [Accessed 15th June 2016]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0120","unstructured":"Global Polio Eradication Initiative. OPV Cessation. Available from: http:\/\/polioeradication.org\/polio-today\/preparing-for-a-polio-free-world\/opv-cessation\/ [Accessed 14 September 2017]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0125","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.33321\/cdi.2014.38.18","article-title":"Polio anywhere is a risk everywhere","volume":"38","author":"Durrheim","year":"2014","journal-title":"Communicable Dis Intellig Quart Rep"},{"key":"10.1016\/j.vaccine.2020.01.080_b0130","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.33321\/cdi.2014.38.19","article-title":"Australia's polio risk","volume":"38","author":"Martin","year":"2014","journal-title":"Communicable Dis Intellig Quart Rep"},{"key":"10.1016\/j.vaccine.2020.01.080_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.33321\/cdi.2009.33.16","article-title":"Immunisation coverage annual report, 2007","volume":"33","author":"Hull","year":"2009","journal-title":"Communicable Dis Intellig"},{"key":"10.1016\/j.vaccine.2020.01.080_b0140","unstructured":"Hull B, Hendry A, Dey A, et al. Annual immunisation coverage report 2015. Sydney: NCIRS; 2017. Available from: http:\/\/www.ncirs.edu.au\/assets\/surveillance\/coverage\/Annual-Immunisation-Coverage-Report-2015.pdf [Accessed 17 August 2017]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1467-842X.2005.tb00748.x","article-title":"National serosurvey of poliovirus immunity in Australia, 1996\u201399","volume":"29","author":"Gidding","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2020.01.080_b0150","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2018.03.086","article-title":"Australian rubella serosurvey 2012\u20132013: On track for elimination?","volume":"36","author":"Edirisuriya","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.080_b0155","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/S0264-410X(02)00255-4","article-title":"A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia","volume":"20","author":"Kelly","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.080_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0950268801005830","article-title":"Impact of the Australian Measles Control Campaign on immunity to measles and rubella","volume":"127","author":"Gilbert","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.01.080_b0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-12-24","article-title":"Deficiency of immunity to poliovirus type 3: a lurking danger?","volume":"12","author":"Reinheimer","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.080_b0170","doi-asserted-by":"crossref","unstructured":"van der Maas NA, Mollema L, Berbers GA, et al. Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 2014;19:20705.","DOI":"10.2807\/1560-7917.ES2014.19.7.20705"},{"key":"10.1016\/j.vaccine.2020.01.080_b0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12879-015-0894-z","article-title":"A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.080_b0180","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1080\/21645515.2015.1016673","article-title":"Is EU\/EEA population protected from polio?","volume":"11","author":"Nijsten","year":"2015","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2020.01.080_b0185","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12889-016-3386-1","article-title":"Seroprevalence of Poliovirus Antibodies in the United States Population, 2009\u20132010","volume":"16","author":"Wallace","year":"2016","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.vaccine.2020.01.080_b0190","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/21645515.2016.1255386","article-title":"Seroprevalence of poliovirus antibodies in the Kansas City metropolitan area, 2012\u20132013","volume":"13","author":"Wallace","year":"2017","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2020.01.080_b0195","article-title":"Assessment of seroprevalence against poliovirus among Italian adolescents and adults","author":"Lupi","year":"2018","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2020.01.080_b0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/aje\/153.3.207","article-title":"Immunity to poliomyelitis in The Netherlands","volume":"153","author":"Conyn-Van Spaendonck","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.01.080_b0205","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(87)92818-2","article-title":"Serological comparisons of approaches to polio vaccination in the Gambia","volume":"1","author":"Hanlon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.01.080_b0210","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.01.080_b0215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2020.01.080_b0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1586\/14760584.2015.1052800","article-title":"Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame","volume":"14","author":"Parker","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.01.080_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.33321\/cdi.1999.23.21","article-title":"Immunisation coverage in Australian children: a systematic review 1990\u20131998","volume":"23","author":"Lister","year":"1999","journal-title":"Communicable Dis Intellig"},{"key":"10.1016\/j.vaccine.2020.01.080_b0230","unstructured":"Fine P, Mulholland K. Community immunity. In: Plotkin S, Orenstein WA, Offit P (editors). Vaccines. 6th. Philadelphia: Elsevier Saunders; 2013."},{"key":"10.1016\/j.vaccine.2020.01.080_b0235","first-page":"226","article-title":"Notifiable diseases surveillance, 1917 to 1991","volume":"17","author":"Hall","year":"1993","journal-title":"Communicable Dis Intellig"},{"key":"10.1016\/j.vaccine.2020.01.080_b0240","unstructured":"Global Polio Eradication Initiative. Two out of three wild poliovirus strains eradicated. 2019. Available from: http:\/\/polioeradication.org\/news-post\/two-out-of-three-wild-poliovirus-strains-eradicated\/ [Accessed 14 November 2019]."},{"key":"10.1016\/j.vaccine.2020.01.080_b0245","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.33321\/cdi.2013.37.21","article-title":"Review of Australia's polio surveillance","volume":"37","author":"Paterson","year":"2013","journal-title":"Communicable Dis Intellig Quart Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:13Z","timestamp":1759401613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20301225"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}